In this pilot study of miRNA expression profiling in single hormone receptor-positive breast cancer we demonstrated that miRNA expression profiles of these tumors depend mainly on their HER2 status, rather than on their hormonal receptor status. The gene discussed is ERBB2; the disease is breast carcinoma.